RepliCel Life Sciences

Illustration of a layer of skin cells

Cell Therapy and Injection Technology

RepliCel is a regenerative medicine company developing autologous cell therapies to treat conditions linked to a deficit of healthy cells required for normal healing and function.

RepliCel continues to advance its cell therapy and dermal injection programs through ongoing research and development.

Our Products

DermaPrecise™

Next-Generation Dermal Injection Technology
DermaPrecise™ is a next-generation dermal injector designed to provide an improved level of control and precision for intradermal (dermis) and subcutaneous (extracellular matrix & fat) injections.
More About DermaPrecise™